David A. Siegel Bioventus Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bioventus Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 141,232 shares of BVS stock, worth $812,084. This represents 0.0% of its overall portfolio holdings.
Number of Shares
141,232
Previous 127,932
10.4%
Holding current value
$812,084
Previous $674,000
8.9%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BVS
# of Institutions
89Shares Held
35.7MCall Options Held
167KPut Options Held
126K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$74.9 Million19.68% of portfolio
-
Juniper Investment Company, LLC New York, NY6.83MShares$39.3 Million18.22% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.81MShares$33.4 Million1.94% of portfolio
-
Sv Health Investors, LLC Boston, MA1.49MShares$8.56 Million32.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.22MShares$7.01 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $355M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...